Evidence map›Paper›PMID 33180676›Full record

ReviewMolecular biology of the cell2020

Alternate histories of cytokinesis: lessons from the trypanosomatids.

Paul C Campbell, Christopher L de Graffenried

Abstract readReview
In one paragraph

Review in Molecular biology of the cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The Trypanosomatids Cell Cycle: A Brief Report.Methods in molecular biology (Clifton, N.J.) · 2022
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paul C CampbellDepartment of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912.
Christopher L de GraffenriedDepartment of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912.

Funding

The role of polo-like kinase in the duplication of the trypanosome cytoskeletonR01AI112953 · NIAID · BROWN UNIVERSITY · PI DE GRAFFENRIED, CHRISTOPHER LUIS · 2015 to 2019
$2.0M
The role of structural inheritance in the positioning of the T. brucei flagellumR21AI115089 · NIAID · BROWN UNIVERSITY · PI DE GRAFFENRIED, CHRISTOPHER LUIS · 2015 to 2016
$447k
NIAID NIH HHS R01 AI112953NIAID NIH HHS R21 AI115089
6 · The paper itself

Abstract

Popular culture has recently produced several "alternate histories" that describe worlds where key historical events had different outcomes. Beyond entertainment, asking "could this have happened a different way?" and "what would the consequences be?" are valuable approaches for exploring molecular mechanisms in many areas of research, including cell biology. Analogous to alternate histories, studying how the evolutionary trajectories of related organisms have been selected to provide a range of outcomes can tell us about the plasticity and potential contained within the genome of the ancestral cell. Among eukaryotes, a group of model organisms has been employed with great success to identify a core, conserved framework of proteins that segregate the duplicated cellular organelles into two daughter cells during cell division, a process known as cytokinesis. However, these organisms provide relatively sparse sampling across the broad evolutionary distances that exist, which has limited our understanding of the true potential of the ancestral eukaryotic toolkit. Recent work on the trypanosomatids, a group of eukaryotic parasites, exemplifies alternate historical routes for cytokinesis that illustrate the range of eukaryotic diversity, especially among unicellular organisms.

Indexed as

Biological EvolutionCell DivisionCytokinesisEvolution, MolecularTrypanosomatina

Identifiers

PMID33180676
PMCPMC7927182

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.